Upexi, Inc. (UPXI)
NASDAQ: UPXI · Real-Time Price · USD
1.160
+0.020 (1.75%)
At close: Oct 1, 2026, 4:00 PM EDT
1.165
+0.005 (0.43%)
After-hours: Oct 1, 2026, 7:57 PM EDT
Company Description
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products.
It offers nail grinder and pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; and functional mushrooms under the Cure Mushrooms brand.
The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform.
It also focuses on cryptocurrency industry and management of cash assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022.
Upexi, Inc. was incorporated in 2018 and is headquartered in Tampa, Florida.
Upexi, Inc.
| Country | United States |
| Founded | 2018 |
| IPO Date | Jun 24, 2021 |
| Industry | Internet Content & Information |
| Sector | Communication Services |
| Employees | 10 |
| CEO | Allan Marshall |
Contact Details
Address: 3030 North Rocky Point Drive, Suite 420 Tampa, Florida 33607 United States | |
| Phone | 727 287 2800 |
| Website | upexi.com |
Stock Details
| Ticker Symbol | UPXI |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| IPO Price | $5.00 |
| CIK Code | 1775194 |
| CUSIP Number | 39959A205 |
| ISIN Number | US39959A2050 |
| Employer ID | 83-3378978 |
| SIC Code | 6199 |
Key Executives
| Name | Position |
|---|---|
| Allan J. Marshall | Chief Executive Officer, President and Chairman of the Board |
| Brian Benjamin Rudick C.F.A. | Chief Strategy Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 29, 2026 | PRE 14A | Other preliminary proxy statements |
| Sep 17, 2026 | 8-K | Current Report |
| Sep 17, 2026 | 10-K | Annual Report |
| Sep 15, 2026 | 8-K | Current Report |
| Sep 14, 2026 | 8-K | Current Report |
| Sep 9, 2026 | 8-K | Current Report |
| Aug 14, 2026 | SCHEDULE 13G/A | Filing |
| Aug 14, 2026 | SCHEDULE 13G | Filing |
| Jul 31, 2026 | 8-K | Current Report |
| Jul 31, 2026 | SCHEDULE 13G/A | Filing |